Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Radical Addition. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109134316B details a mild synthesis of fluoroalkylsulfonyl fluorides for JAK inhibitors. Discover cost-effective manufacturing and supply chain advantages.
Novel Grignard-based route for glufosinate-ammonium. Reduces waste, improves yield, and ensures safe commercial scale-up for agrochemical manufacturers.
Discover a green, visible-light mediated method for synthesizing phosphorylated quinazolinone compounds. This novel route offers significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN119735606B details visible-light synthesis of gem-bis boron cyclopropanes. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN119219602A reveals a novel Cu-catalyzed radical cyclization for 4-lauryl-β-lactam derivatives, offering high atom economy and scalable pharmaceutical intermediate production.
Novel nickel-catalyzed synthesis of beta-iododifluoroacetone derivatives offers high yield and scalability for pharmaceutical intermediates manufacturing supply chain cost reduction.
Patent CN110872218B reveals a green Cu-catalyzed route for benzofluorenone synthesis. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN115403494B enables air-oxidized, metal-free synthesis of beta-hydroxy sulfones. Delivers high purity, cost efficiency, and scalable supply for pharmaceutical intermediates.
Patent CN111517904A reveals a mild, catalyst-free method for sulfonylacetonitriles. This route offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN111253293B reveals efficient iron-catalyzed synthesis. Delivers high-purity intermediates with significant cost reduction in pharmaceutical manufacturing.
Patent CN109456180A reveals metal-free synthesis of β,β-dichlorolactone. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN101628904B details a Mn(OAc)3-promoted synthesis. Offers high yield, mild conditions, and green solvent usage for pharmaceutical intermediates.
Patent CN107513056A enables metal-free quinoline synthesis with high atom economy enhancing supply chain reliability cost reduction in pharmaceutical manufacturing
Solve multi-step synthesis challenges for 4H-naphthoquinoline derivatives. 60%+ yield, broad functional group tolerance. Scale to 100MT/yr.